Developer docs
API playgroundTry for free, no card

Search company profiles

Carasent

Full company profile

uuid000bxn8

Namestring
Carasent
Legal namestring
Carasent AB (publ)
Websiteurl
carasent.com
Company typeenum
Public
Founded yearint
1997
Descriptiontext

Carasent is a Nordic investment-management and operating company focused on building a portfolio of e-health and entrepreneurial software businesses. Per public-filing references, its listed legal entity is Carasent AB (publ), a Swedish public limited company traded on OTCMKTS under the ticker APXZF, with headquarters in Oslo, Norway, and 101–250 employees. The firm's stated role is to provide services to businesses developing entrepreneurial and e-health solutions, functioning as a buy-and-build platform in the healthcare-software sector.

The company's core activity is the acquisition and operation of small-to-mid-sized Nordic e-health software companies. Since 2020 it has executed at least five acquisitions: Avans Soma (2020), Metodika (2021), Medrave (2021), HPI Health Profile Institute (2022), and InfoSolutions Sverige (2026). These portfolio companies deliver clinical-software, health-profile/assessment, and information-systems products to healthcare providers in Sweden and the broader Nordics. Group revenue, based on disclosed financials, has grown from roughly $15M in 2021 to roughly $37M in 2025, with growth driven materially by acquisition activity in addition to organic scaling.

Carasent's business model is a software rollup: it acquires niche healthcare-software vendors, applies shared operational resources, and monetizes primarily through licensed software and recurring service fees paid by healthcare customers. The company is led by Chairman of the Board Tomas Meerits, with broader management, pricing, and product detail not disclosed in the available sources. No detailed pricing, channel, or marketing information is available; revenue is not separately broken out in the provided earnings-call materials.

Short descriptiontext

Carasent is a Nordic investment-management and operating company that acquires and develops e-health and entrepreneurial software businesses, primarily serving healthcare providers in Sweden and the wider Nordics through its portfolio of clinical and health-profile software products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersOslo, Norway
HQ citystring
Oslo
HQ countrystring
Norway
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
e-health software, healthcare practice management, medical practice software, health information systems, patient management platforms
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Healthcare Practice Management Software
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Carasent is a publicly traded Swedish investment and operating company that acquires, owns, and develops businesses providing entrepreneurial and e-health software solutions to healthcare providers. Its portfolio companies deliver practice management, patient administration, health profiling, and clinical workflow software primarily to healthcare practices across the Nordics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product or service information was available in the provided sources.

Product and service1 record
1E-health practice management software portfolio
CategoryHealthcare Practice Management Software
Description

A portfolio of e-health and practice management software products delivered through Carasent's acquired subsidiaries, serving healthcare providers with patient administration, health profiling, and clinical workflow capabilities.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1CompuGroup Medical
TypeBroad incumbent
Description

European e-health incumbent offering practice software, EHR, and clinical solutions to physicians and hospitals. Direct functional overlap with Carasent's e-health portfolio thesis, but at much larger pan-European scale.

2Evolent Health
TypeOthers
Description

US-listed healthcare-specialty platform using acquisition and value-based-care operating models. Not a direct competitor but a thematic peer illustrating how public-company health-tech roll-ups are valued and scaled, relevant for benchmarking Carasent's capital-markets profile.

3Dedalus Group
TypeBroad incumbent
Description

Pan-European healthcare-IT group built largely through M&A, offering clinical and diagnostic software across multiple countries. Mirrors Carasent's roll-up strategy at significantly larger scale and geographic breadth.

4Sectra
TypeDirect peer
Description

Swedish-listed health-IT company focused on imaging IT, EHR-adjacent modules, and cybersecurity for healthcare. Comparable Nordic footprint, public-company profile, and acquisition-led growth playbook make it Carasent's closest direct peer.

5Visiba Care
TypeEmerging player
Description

Nordic digital-care platform specializing in virtual consultations and patient triage. Adjacent e-health product set to Carasent's portfolio and competing for the same Nordic healthcare-provider customers.

6Doctrin
TypeEmerging player
Description

Swedish health-tech company offering digital triage and remote consultation tools to primary-care providers. Comparable Nordic e-health niche and similar target customer segment to Carasent's portfolio companies.

7Platform24
TypeEmerging player
Description

Nordic healthcare engagement platform providing virtual care, patient triage, and EHR-integrated workflows. Overlaps Carasent's e-health vertical and shares the same Swedish/Nordic enterprise customer base.

8CGM (Norwegian operations)
TypeRegional player
Description

CompuGroup Medical's Norwegian and Nordic physician-software operations compete with Carasent's portfolio companies in the same Oslo-area and broader Norwegian e-health market, making them directly comparable regional competitors.

9Cambio Healthcare Systems
TypeDirect peer
Description

Nordic EHR and healthcare-IT vendor with strong Swedish and Scandinavian hospital presence. Directly comparable in target market (Nordic clinicians) and category (clinical e-health software) to Carasent's portfolio companies.

10TietoEVRY (Tietoevry Care)
TypeBroad incumbent
Description

Large Nordic IT services group with a dedicated healthcare and social-care software unit serving Nordic public-sector and provider customers. Direct overlap with Carasent's Nordic e-health vertical, but as part of a much broader IT portfolio.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carasent

Healthcare Practice Management Softwarecarasent.com

Carasent is a Nordic investment-management and operating company that acquires and develops e-health and entrepreneurial software businesses, primarily serving healthcare providers in Sweden and the wider Nordics through its portfolio of clinical and health-profile software products.

What Carasent does

Carasent is a Nordic investment-management and operating company focused on building a portfolio of e-health and entrepreneurial software businesses. Per public-filing references, its listed legal entity is Carasent AB (publ), a Swedish public limited company traded on OTCMKTS under the ticker APXZF, with headquarters in Oslo, Norway, and 101–250 employees. The firm's stated role is to provide services to businesses developing entrepreneurial and e-health solutions, functioning as a buy-and-build platform in the healthcare-software sector.

The company's core activity is the acquisition and operation of small-to-mid-sized Nordic e-health software companies. Since 2020 it has executed at least five acquisitions: Avans Soma (2020), Metodika (2021), Medrave (2021), HPI Health Profile Institute (2022), and InfoSolutions Sverige (2026). These portfolio companies deliver clinical-software, health-profile/assessment, and information-systems products to healthcare providers in Sweden and the broader Nordics. Group revenue, based on disclosed financials, has grown from roughly $15M in 2021 to roughly $37M in 2025, with growth driven materially by acquisition activity in addition to organic scaling.

Carasent's business model is a software rollup: it acquires niche healthcare-software vendors, applies shared operational resources, and monetizes primarily through licensed software and recurring service fees paid by healthcare customers. The company is led by Chairman of the Board Tomas Meerits, with broader management, pricing, and product detail not disclosed in the available sources. No detailed pricing, channel, or marketing information is available; revenue is not separately broken out in the provided earnings-call materials.

Carasent firmographics

Firmographics
Name
Carasent
Legal name
Carasent AB (publ)
Website
https://carasent.com
Company type
Public
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Carasent is a Nordic investment-management and operating company that acquires and develops e-health and entrepreneurial software businesses, primarily serving healthcare providers in Sweden and the wider Nordics through its portfolio of clinical and health-profile software products.
Ownership category
akta.pro rank

Where Carasent is headquartered

Location

Headquarters

HQ city
Oslo
HQ country
Norway
HQ region
Europe

Markets served

Carasent business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Carasent product offering

Product offering

Core offering

Carasent is a publicly traded Swedish investment and operating company that acquires, owns, and develops businesses providing entrepreneurial and e-health software solutions to healthcare providers. Its portfolio companies deliver practice management, patient administration, health profiling, and clinical workflow software primarily to healthcare practices across the Nordics.

Product overview

No product or service information was available in the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • E-health practice management software portfolio A portfolio of e-health and practice management software products delivered through Carasent's acquired subsidiaries, serving healthcare providers with patient administration, health profiling, and clinical workflow capabilities.

Companies that use Carasent

Customer profile

Ideal customer profiles1 record

Carasent technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Carasent partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Carasent competitors and assessment

Company assessment

Broad incumbents

  • CompuGroup Medical: European e-health incumbent offering practice software, EHR, and clinical solutions to physicians and hospitals. Direct functional overlap with Carasent's e-health portfolio thesis, but at much larger pan-European scale.
  • Dedalus Group: Pan-European healthcare-IT group built largely through M&A, offering clinical and diagnostic software across multiple countries. Mirrors Carasent's roll-up strategy at significantly larger scale and geographic breadth.
  • TietoEVRY (Tietoevry Care): Large Nordic IT services group with a dedicated healthcare and social-care software unit serving Nordic public-sector and provider customers. Direct overlap with Carasent's Nordic e-health vertical, but as part of a much broader IT portfolio.

Others

  • Evolent Health: US-listed healthcare-specialty platform using acquisition and value-based-care operating models. Not a direct competitor but a thematic peer illustrating how public-company health-tech roll-ups are valued and scaled, relevant for benchmarking Carasent's capital-markets profile.

Direct peers

  • Sectra: Swedish-listed health-IT company focused on imaging IT, EHR-adjacent modules, and cybersecurity for healthcare. Comparable Nordic footprint, public-company profile, and acquisition-led growth playbook make it Carasent's closest direct peer.
  • Cambio Healthcare Systems: Nordic EHR and healthcare-IT vendor with strong Swedish and Scandinavian hospital presence. Directly comparable in target market (Nordic clinicians) and category (clinical e-health software) to Carasent's portfolio companies.

Emerging players

  • Visiba Care: Nordic digital-care platform specializing in virtual consultations and patient triage. Adjacent e-health product set to Carasent's portfolio and competing for the same Nordic healthcare-provider customers.
  • Doctrin: Swedish health-tech company offering digital triage and remote consultation tools to primary-care providers. Comparable Nordic e-health niche and similar target customer segment to Carasent's portfolio companies.
  • Platform24: Nordic healthcare engagement platform providing virtual care, patient triage, and EHR-integrated workflows. Overlaps Carasent's e-health vertical and shares the same Swedish/Nordic enterprise customer base.

Regional players

  • CGM (Norwegian operations): CompuGroup Medical's Norwegian and Nordic physician-software operations compete with Carasent's portfolio companies in the same Oslo-area and broader Norwegian e-health market, making them directly comparable regional competitors.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Carasent social profiles

Digital presence

Carasent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carasent leadership team

Management profile

Number of profiles

Profiles1 record

Carasent funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carasent M&A and investment

M&A and investment

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carasent

What does Carasent do?

Carasent is a publicly traded Swedish investment and operating company that acquires, owns, and develops businesses providing entrepreneurial and e-health software solutions to healthcare providers. Its portfolio companies deliver practice management, patient administration, health profiling, and clinical workflow software primarily to healthcare practices across the Nordics.

Is Carasent a public or private company?

Carasent is a public company. It is classified as public and is currently operating.

When was Carasent founded?

Carasent was founded in 1997. It employs 101 to 250 people.

Where is Carasent based?

Carasent is headquartered in Oslo, Norway, in the Europe region.

Who are Carasent's main competitors?

Broad incumbents on record are CompuGroup Medical, Dedalus Group and TietoEVRY (Tietoevry Care). Evolent Health is listed as an others. Direct peers are Sectra and Cambio Healthcare Systems. Emerging players are Visiba Care, Doctrin and Platform24. CGM (Norwegian operations) is listed as a regional player.

Does Carasent have an API?

No public API is recorded for Carasent.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seeking AlphaCarasent AB (publ) (APXZF) Q2 2026 Earnings Call TranscriptCarasent AB reported strong Q2 2026 results with more than 90% recurring revenues, 15% organic ARR growth, and 110% net revenue retention, while announcing the completion of its long-pursued acquisition of Infosolutions. Sign-up implemented increased from SEK 4 million in Q1 to SEK 6 million in Q2, with most sales driven by Webdoc. The CEO highlighted the Infosolutions acquisition as an extremely important strategic addition to Carasent's product portfolio serving the healthcare sector.YahooCarasent AB (publ) (FRA:E0C) (H1 2026) Earnings Call Highlights: Strong ARR Growth and ...Carasent AB reported strong H1 2026 earnings with over 90% recurring revenue, 29% total ARR growth reaching 97.7 million in revenue, and 110% net revenue retention, indicating robust customer retention and upsell performance. The company successfully acquired InfoSolutions, adding approximately 40 million in ARR while achieving a 25% personnel cost reduction at InfoSolutions through administrative restructuring. Challenges remain including weak historical profitability at InfoSolutions requiring ongoing restructuring, higher churn in the German market from legacy products, and cautious adoption of the MedSum AI system due to regulatory concerns in healthcare.Investing.comCarasent Q2 2026 slides: ARR hits SEK 401m, margins expand to 19% By Investing.comCarasent reported strong second-quarter 2026 results on July 10, with contracted annual recurring revenue reaching SEK 401 million, representing 29% year-over-year growth, while adjusted EBITDA margins expanded to 19%. The Stockholm-listed electronic health records provider generated SEK 97.7 million in revenue (up 18% YoY) and successfully integrated the InfoSolutions acquisition, which contributed SEK 42 points of ARR growth, while launching its Medsum AI assistant with approximately 200 paying users generating SEK 2 million in ARR.Investing.comCarasent Q2 2026 slides: ARR hits SEK 401m, margins expand to 19% By Investing.comCarasent reported second-quarter 2026 results on July 10, with contracted annual recurring revenue reaching SEK 401 million, representing 29% year-over-year growth including 15% organic expansion. The Stockholm-listed electronic health records provider saw adjusted EBITDA margins expand to 19% and revenue increase 18% to SEK 97.7 million, driven by strong subscription performance and the InfoSolutions acquisition. The company also highlighted rapid adoption of its Medsum AI assistant, which grew to approximately 300 active users generating SEK 2 million in ARR, while outlining plans to launch WEBCUR in Germany and achieve full sales momentum in Q4.AInvestCarasent's Q2 2026 Update: Is the Nordic Healthcare IT Turnaround Real or Just Hope?Carasent, a Nordic healthcare technology company with a market cap of approximately SEK 1.56 billion, published its Q2 2026 interim report showing Q2 2025 net sales growth of 26% (split evenly between 13% organic growth and 14% from acquisitions/divestments) and H1 organic recurring revenue growth of 14%. The article examines whether the company's previous turnaround fixes—including organizational restructuring within Ad Opus due to underperformance and high churn, and addressing the Volvat project's excess capacity usage—have created lasting operational discipline or represent temporary improvements. Analysts and investors are scrutinizing whether organic growth can sustain without acquisition support and whether restructuring costs are genuinely declining rather than being deferred.Seeking AlphaCarasent AB (publ) 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:APXZF) 2026-07-10Carasent AB (publ) published a slide deck in conjunction with their 2026 Q2 earnings call, as documented by Seeking Alpha's transcript team. The actual content of the earnings presentation, including financial figures, operational metrics, or strategic commentary, is not present in this scraped page. This appears to be an announcement page rather than the substantive earnings call transcript or results announcement itself.NewsnReleasesCarasent acquires Infosolutions in SEK 115Mn deal to cement dominance in Swedish private healthcareCarasent agreed to acquire Infosolutions Sverige AB for SEK 115 million, paying 90% cash and 10% shares. The deal values the EHR middleware at SEK 115M, with 2025 revenue of SEK 67M and recurring revenue of SEK 41M. Completion is expected in Q2 2026.CarasentCarasent acquires Infosolutions and strengthens its position in Swedish private healthcareCarasent committed to acquire Infosolutions Sverige AB, a Swedish EHR-lab/radiology connector, for SEK 115 million. The deal is 90% cash and 10% shares, with completion expected in Q2 2026. Infosolutions reported SEK 67 million revenue in 2025.MarketScreenerCarasent acquires Infosolutions for SEK 115 millionCarasent acquired Infosolutions for SEK 115 million, financing 90% in cash and 10% in treasury shares. Infosolutions, which integrates healthcare EHR systems with labs, reported SEK 67 million revenue last year. The deal is expected to close in Q2 2026.